» Articles » PMID: 35027863

Diagnostic Benefit of the Detection of Mitotic Figures in Endometriotic Lesions

Overview
Date 2022 Jan 14
PMID 35027863
Authors
Affiliations
Soon will be listed here.
Abstract

Endometriosis is a chronic disease which is diagnosed by surgical intervention combined with a histological work-up. Current international and national recommendations do not require the histological determination of the proliferation rate. The diagnostic and clinical importance of the mitotic rate in endometriotic lesions still remains to be elucidated. In this retrospective study, the mitotic rates and clinical data of 542 patients with histologically diagnosed endometriosis were analyzed. The mean patient age was 33.5 ± 8.0 (17 - 72) years, and the mean reproductive lifespan was 21.2 ± 7.8 (4 - 41) years. Patients were divided into two groups and patients' reproductive history and clinical endometriosis characteristics were compared between groups. The study group consisted of women with confirmed mitotic figures (n = 140, 25.83%) and the control group comprised women without proliferative activity according to their mitotic rates (n = 402, 74.27%). Women with endometriotic lesions and histologically confirmed mitotic figures were significantly more likely to have a higher endometriosis stage (p = 0.001), deep infiltrating endometriosis (p < 0.001), ovarian endometrioma (p = 0.012), and infertility (p = 0.049). A mitotic rate > 0 was seen significantly less often in cases with incidental findings of endometriosis (p = 0.031). The presence of symptoms and basic characteristics such as age, age at onset of menarche, reproductive lifespan and parity did not differ between the group with and the group without mitotic figures. This study shows that a simple histological assessment of the mitotic rate offers additional diagnostic value for the detection of advanced stages of endometriosis. The possible role as a predictive marker for the recurrence of endometriosis or the development of endometriosis-associated cancer will require future study.

References
1.
Findeklee S, Radosa J, Hamza A, Haj Hamoud B, Iordache I, Sklavounos P . Treatment algorithm for women with endometriosis in a certified Endometriosis Unit. Minerva Ginecol. 2020; 72(1):43-49. DOI: 10.23736/S0026-4784.20.04490-1. View

2.
Nepomnyashchikh L, Lushnikova E, Molodykh O, Pichigina A . Immunocytochemical analysis of proliferative activity of endometrial and myometrial cell populations in focal and stromal adenomyosis. Bull Exp Biol Med. 2013; 155(4):512-7. DOI: 10.1007/s10517-013-2190-5. View

3.
Nisolle M, Donnez J . Immunohistochemical analysis of proliferative activity and steroid receptor expression in peritoneal and ovarian endometriosis. Fertil Steril. 1997; 68(5):912-9. DOI: 10.1016/s0015-0282(97)00341-5. View

4.
Kho R, Andres M, Borrelli G, Neto J, Zanluchi A, Abrao M . Surgical treatment of different types of endometriosis: Comparison of major society guidelines and preferred clinical algorithms. Best Pract Res Clin Obstet Gynaecol. 2018; 51:102-110. DOI: 10.1016/j.bpobgyn.2018.01.020. View

5.
Abbas S, Ihle P, Koster I, Schubert I . Prevalence and incidence of diagnosed endometriosis and risk of endometriosis in patients with endometriosis-related symptoms: findings from a statutory health insurance-based cohort in Germany. Eur J Obstet Gynecol Reprod Biol. 2011; 160(1):79-83. DOI: 10.1016/j.ejogrb.2011.09.041. View